Axiom (Biotechnology)

San Francisco, CA · Privately Held (backing)

Developer of a biotechnology platform designed to help scientists predict and mitigate drug toxicity earlier in the development process. Axiom (Biotechnology) is based in San Francisco, CA. Its last reported valuation was $121 million in Apr 2025. It has raised $30 million.

Last reported valuation
$121.0M
Oct 2026
Priced at
—
Total raised
$30.0M
Last round
—

Who backs Axiom (Biotechnology)?

14 investors
InvestorType
Abstract VenturesVenture capital
CRVVenture capital
Jeff DeanOther
Amplify PartnersVenture capital
Dimension (United States)Venture capital
Dimension Capital ManagementFamily office
Alec NielsenAngel
Ari Morcos—
Atria Ventures—
Barry McCardel—
+ 4 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Axiom (Biotechnology) investors

14 investors are on record for Axiom (Biotechnology), including Abstract Ventures, CRV, Jeff Dean and Amplify Partners. By type, the record holds 4 venture capital firms, 1 family office and 1 angel investor.

Free account
More of Axiom (Biotechnology) with a free account
  • ·The complete investor list: 14 names
  • ·Watch Axiom (Biotechnology): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 14 firms already write checks for companies like Axiom (Biotechnology). Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View